Juvenile dermatomyositis

Overview

Juvenile dermatomyositis (JDM) is an autoimmune condition that starts in childhood, mainly causing muscle weakness and a skin rash, though it can affect several body systems at once. It's the most common form of childhood inflammatory myositis, and while closely related to the adult form (dermatomyositis), it has some differences in how it presents and how it's typically managed.

Symptoms

A patchy red or purple rash is common, often on the eyelids, face, neck, the backs of the shoulders, the chest, or the backs of the hands and fingers — it can look different depending on skin tone, tends to itch, hurt or swell, and gets worse in the sun. Severe cases can affect the fat layer under the skin (making it thinner or firmer) or cause ulcers.

Muscle weakness typically develops gradually over weeks or months, affecting the trunk, shoulders, upper arms, thighs and buttocks — making standing up, climbing stairs, or lifting the arms overhead harder, and walking and running more tiring. Some children have swallowing difficulty or voice changes if the throat muscles are affected, and breathing problems if the chest muscles are involved.

Small, hard calcium deposits can form under the skin or within muscle (calcinosis), and where muscle inflammation combines with this calcium build-up, joints can become harder to fully straighten. Lung inflammation can cause a dry cough or breathlessness with activity that used to be easy, and — left untreated — can progress to scarring and, rarely, become life-threatening. Gut involvement can cause stomach pain, vomiting, diarrhoea or difficulty absorbing nutrients. Muscle aching, fatigue, and delays in growth and development (from ongoing inflammation and weakness) round out the picture.

Cause

JDM is believed to be autoimmune — the immune system mistakenly attacking healthy tissue — rather than directly inherited, though some children may inherit a general tendency toward autoimmune conditions.

Getting a diagnosis

Specialists combine clinical examination with tests as needed — blood work (including creatine kinase and specific myositis-related antibodies), MRI, EMG, muscle biopsy, and sometimes a CT chest scan. The particular combination of muscle weakness and skin rash is often distinctive enough to guide diagnosis directly.

Management and outlook

Care is usually led by a neurologist at a specialist neuromuscular clinic, or a rheumatologist, with treatment broadly similar to adult dermatomyositis but dosed by body weight — and starting treatment early generally leads to a better outcome. Where the rash is the main issue, topical steroid or tacrolimus creams help directly; systemic treatment usually starts with prednisolone at a higher dose, tapered down as things improve, though milder cases may be managed with disease-modifying drugs (DMARDs) like methotrexate, azathioprine or mycophenolate alone — these take longer to work but are generally safer for long-term use than steroids.

For more severe, treatment-resistant cases, biological therapies (infliximab, rituximab) or a course of IVIG (intravenous immunoglobulin, given over 3–5 days) may be used. Physiotherapy helps maintain strength, prevent contractures and support heart health, and occupational therapy can provide equipment or adaptations where weakness or contractures make everyday tasks harder.